Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeFUNDINGQ'Apel Medical Raises $22 Million: Funds Will Help Grow a Highly Innovative...

Q’Apel Medical Raises $22 Million: Funds Will Help Grow a Highly Innovative Neurovascular Access Platform

February 11, 2021

Q’Apel Medical notes the round included River Cities Capital, Soleus Capital, and incumbent investor Research Corporation Technologies (RCT). Q’Apel Medical is an innovative neurovascular company specializing in developing and commercializing novel access technology for vascular interventions.

“With our three-pronged approach that involves increasing manufacturing, expanding into newer geographies, and developing innovative products, Q’Apel is perfectly poised to become the preferred catheter technology vendor across the healthcare sector. In addition, having Scott Huennekens and Carter McNabb join our Board of Directors will be extremely valuable. Both Scott and Carter bring extensive experience, especially in high-growth medical device companies, building businesses both in the U.S. and internationally.” said King Nelson, CEO of Q’Apel Medical.

“Q’Apel’s technology has the ability to revolutionize vascular access and improve patient care. There is no better team to lead this effort; between strong existing physician relationships and a deep understanding of the neurovascular market, this team will execute effectively and efficiently,” said Carter McNabb.

“I admire Q’Apel Medical for its highly innovative products and dynamic leadership team, and I’m honored to be joining their board. I have tremendous respect for King, Chris and the other board members, and I look forward to working with them,” said Scott Huennekens

Q’Apel Medical products are already being utilized in over 130 hospital systems nationwide. In 2021, Q’Apel plans to significantly increase its manufacturing capacity, add additional head count and expand their product portfolio. At the same time, the company is in the process of acquiring CE certification, which will allow Q’Apel to expand into Europe later this year.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy